Anti-obesity drugs can be boost for food makers, investors say
The growth in demand for appetite suppressing anti-obesity drugs like Novo Nordisk’s (NOVOb.CO) Wegovy presents opportunities for food manufacturers and the market’s initially downbeat reaction may be ...